Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pallini

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Cell Death and Differentiation|November 24, 2012
Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomasC Ciceroni, M Bonelli, E Mastrantoni, et al.
Cell Death and Differentiation|April 28, 2012
A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cellsC M Tate, R Pallini, L Ricci-Vitiani, et al.
Neuropharmacology|July 16, 2008
Type-3 metabotropic glutamate receptors negatively modulate bone morphogenetic protein receptor signaling and support the tumourigenic potential of glioma-initiating cellsC Ciceroni, A Arcella, P Mosillo, et al.
Cell Death & Disease|May 10, 2014
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivoM Signore, F Pelacchi, S di Martino, et al.
Cancer Research|May 19, 2001
Gadolinium in human glioblastoma cells for gadolinium neutron capture therapyG De Stasio, P Casalbore, R Pallini, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Cell Death and Differentiation|November 24, 2012
Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomasC Ciceroni, M Bonelli, E Mastrantoni, et al.
Cell Death and Differentiation|April 28, 2012
A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cellsC M Tate, R Pallini, L Ricci-Vitiani, et al.
Neuropharmacology|July 16, 2008
Type-3 metabotropic glutamate receptors negatively modulate bone morphogenetic protein receptor signaling and support the tumourigenic potential of glioma-initiating cellsC Ciceroni, A Arcella, P Mosillo, et al.
Cell Death & Disease|May 10, 2014
Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivoM Signore, F Pelacchi, S di Martino, et al.
Cancer Research|May 19, 2001
Gadolinium in human glioblastoma cells for gadolinium neutron capture therapyG De Stasio, P Casalbore, R Pallini, et al.
Pageof 10